Utility of CA 15-3 and CEA in monitoring breast cancer patients with bone metastases: special emphasis on "spiking" phenomena. [electronic resource]
- Clinical biochemistry Feb 1997
- 53-6 p. digital
Publication Type: Journal Article
0009-9120
10.1016/s0009-9120(96)00133-6 doi
Biomarkers, Tumor--blood Bone Neoplasms--blood Breast Neoplasms--blood Carcinoembryonic Antigen--blood Disease Progression Female Humans Middle Aged Mucin-1--blood